This trial is active, not recruiting.

Condition healthy subjects
Sponsor University of Minnesota - Clinical and Translational Science Institute
Start date March 2014
End date March 2018
Trial size 120 participants
Trial identifier NCT02074722, 1312M46727


Mind-Body Awareness Training (MBAT), in the forms of various yoga and meditative practices, has become increasingly prevalent due to an increase in awareness of the potential health benefits, and improvements in concentration that this training can provide to practitioners. In the present study, we investigate the role of Mind-Body Awareness Training (MBAT) in the initial learning of a sensorimotor (SMR) based Brain-Computer Interface (BCI).

The PI's hypothesis is that MBAT will improve performance in SMR based BCI.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Time perspective prospective
Healthy Subjects

Primary Outcomes

Performance over BCI sessions
time frame: one to three months

Eligibility Criteria

Male or female participants from 18 years up to 64 years old.

Inclusion Criteria: - 18-64 years old healthy subjects Exclusion Criteria: - History of traumatic brain injury/brain lesion, history of neurological deficit or neurodegenerative disorder, or history of epileptic seizures.

Additional Information

Official title Brain-Computer Interface and Mind-Body Awareness Training
Principal investigator Bin He, PhD
Description In this protocol, we will test the PI's hypothesis that MBAT including yoga will improve the ability for subjects to concentrate on control the SMR thus improving the performance of BCI. Subjects will be recruited for short term MBAT and then undergo BCI training. The performance of subjects with MBAT will be compared with those without MBAT to test the hypothesis. Procedures involved include 6 weeks yoga classes with at least 3 classes per week, and a EEG brain noninvasive brain computer interface study.
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by University of Minnesota - Clinical and Translational Science Institute.